Ms Rosemary Steen:

On disputes, I was very clear when I started as director that I wanted to prioritise that area within the regulatory body for action, and not just related to the changes that are now happening. The RTB has always had to deal with changes in regulatory regimes or legislation. We were talking about it this morning. The RTB is in its 20th year. We have had significant experience in adapting to different things. I was clear that disputes were a critical issue. That was why we drove investment in the new platform we launched last week, which was also to protect everybody in the context of further changes and disputes that would happen as a result of pressures around the market. I am happy we made that decision. We deprioritised investment in other parts of the business to do that. It was the right thing to do based on feedback from stakeholders. We had 26 stakeholders at clinics last week and yesterday giving feedback on the new system. The community is happy this is now in place and everybody will be able to access it in the context of whatever changes lie ahead.

It is clear that the challenges around the market are going to remain over the next year. We have to be in a position to service all of those disputes as quickly as possible.